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Abstract 
 
The drug development process requires the complete evaluation and identification of the 
chosen substance as well as its properties. It involves extensive chemical examination to 
achieve the best therapeutic effects which demands huge expenditure both in terms of 
time and money. Computer aided molecular design (CAMD) allows the production of new 
substances with pre-decided properties. Additionally, in order to illustrate and determine 
the interrelationship between the chemical structure of a compound and its biological 
activity, Quantitative Structure Activity Relationship (QSAR) is applied by employing a 
mathematical model and arranging molecular descriptors. This paper presents review of 
CAMD and QSAR techniques. The most common chemometric techniques are also 
emphasized. CAMD and QSAR are considered to be extremely efficient instruments in 
molecular design and accelerate the initial steps of drug development process. 
Furthermore, they enhance the effectiveness and reduce the cost of newly developed 
drugs.   
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1.0  INTRODUCTION 
 
There have been exciting developments in 
computational chemistry and computer aided 
molecular design (CAMD) and it has come up as a 
new branch of chemistry with tremendous potential. 
Investors have been lured back towards the field of 
theoretical research due to new technological 
methods that can deliver artificial compounds 
endowed with the required properties thus 
decreasing the amount of money that needs to be 
pumped in this field. 
At present, development of new drugs and search 
for substances with the required pharmacokinetic 
properties has opened up new avenues for CAMD. A 
sub branch of CAMD [1] known as computer aided 
drug design (CADD) [2-4] specifically focuses on 
producing substances with a pre-decided set of 
properties. Various revolutionary technologies play 
an important role in this field and include simulation 
software, molecular modeling and Quantitative 
Structure Activity Relationship (QSAR) which has 
been restructured of late. CAMD works on the basis 
of certain processes which include determination of 
the structural framework which will confer the 
required property on a compound, initiating ligand 
receptor binding, in depth analysis of different 
biological mechanisms , studying the chemical 
reactivity of substances, development of novel 
substances with chemical action, determination of 
the presence of active lead compounds and laying 
down projections for compounds with structural 
similarities which are still in the pipeline. All these 
properties help CAMD to be an extremely efficient 
instrument in molecular design and specifically in 
development of new drugs. 
The first step in development of any new drug is 
identification of a substance with the required 
properties. After the structural framework of the 
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candidate compound has been determined, various 
compounds with similar structure with the required 
properties are analyzed to achieve the best possible 
therapeutic effect and pharmacokinetic activity 
reducing the adverse effects to a minimum. The 
compounds undergo extensive testing in humans 
and animals covering aspects like therapeutic effect, 
mode of action, bio-availability, presence of side 
effects, market requirements, manufacturing set up 
needed and its space in the medical realm. The 
process of drug development has been conceived 
as a trial and error method which entails huge 
expenditure both in terms of time and money. 
Of late, drug manufacturers have tried to use 
rational drug design and the existing drug 
development process in combination. So, the 
conventional trial and error method now have the 
support of sophisticated software programs, 
computerized measurement and analysis and other 
revolutionary technologies. The drug development 
process has also benefitted from the technological 
leaps in the field of combinatorial chemistry and 
biotechnological fields which focus on the study of 
proteins and genes. Various technologies work as a 
choir to enhance the effectiveness of the drug 
development process. 
The basic mechanism that lies behind 
combinatorial chemistry is the use of High Throughput 
Screening (HTS) to analyze a mind –boggling number 
of compounds. All these compounds were analyzed 
by HTS Vis-a –Vis their effectiveness against any 
potential threatening agent which may be identified 
as an abnormal protein which may be behind the 
pathogenesis of a disease. In the next step, data 
mining software is used to separate the new 
arrangements that come up in the analysis that can 
then be used to study other combinations of data. 
The field of computers has improved by leaps and 
bounds both in terms of the speed and the volume of 
information it can process and these developments 
over the past ten years have brought forward 
thousands of lead compounds in the scientific realm 
for further analysis. An avalanche of potential drug 
candidates has occurred due to advanced 
technology and the financial costs and the time 
involved in the drug development process have 
been cut down significantly thus making the entire 
process a more cost effective one. 
Statistics show that around 5000 potential drug 
candidates have to be screened to get one genuine 
candidate. It also has to be kept in mind that all 
candidates have to clear the tests of safety, adverse 
effects, efficacy in clinical trials and the net result 
comes out to be that only one out of ten candidates 
manages to clear all these tests. So, it can be 
concluded that though the initial steps of the drug 
development process have been accelerated due 
to technological advances the stages of clinical trials 
have remained untouched by their benefits and are 
the stages that use the maximum amount of time 
and money in the entire drug development process. 
A study shows that by 2013, the total cost of finally 
delivering a drug to consumer came out to be 1000 
million dollars [5]. 
The QSAR methods were applied in an effort to 
make the process more cost effective, these 
methods tried to find the interrelationship between 
the structural composition of a compound and its 
biological properties describing it by means of 
molecular structural descriptors.  
There is a provision for actual quantitative 
measurement of descriptor variables in QSAR; they 
are calculated by computer programs so they hold 
good for a large number of compounds. The QSAR 
approach is based on the development of a model 
which will be applicable to a large number of 
compounds and can describe the interrelationship 
between structural framework and biological activity 
or therapeutic effect. Another technique that is used 
is that once the interrelationship between structural 
composition and biological activity is defined and 
understood then the biological activity of a new 
chemical substance can be predicted by using this 
model. As far as drug development is concerned the 
basic purpose served by QSAR is to screen all 
potential candidates in terms of side effects and 
clinical benefits in trials thus determining which 
chemical compound has the capability of acting like 
a drug. 
The defining principle behind QSAR is that the 
structural composition of any compound is the 
determining factor of its biological properties [6, 7]. It 
also takes into account the similarity principle and 
considers compounds with similar structural 
configurations to have similar biological properties 
thus specific descriptors can be assigned to a 
specific structural composition. The similarity principle 
can only work if there is a provision of a technique 
that can analyze the similarities in the structural 
framework of different compounds; the Quantitative 
Structure Activity Relationships Theory provides a 
solution to this problem. 
This paper presents the new CAMD advances and 
highlights the recent development of QSAR 
techniques. First, it introduces the historical birth and 
development of QSAR techniques. The QSAR field 
has significantly evolved since its qualitative origins, 
to the actual three-dimensional and higher 
dimensional models, going through the linear free 
energy relationships, the Hansch analysis, and the 
QSAR based on topological descriptors. In addition, 
this section also describes the generation of 
descriptors, the statistical treatment of Similarity 
Matrices (SM), and the validation of results. The most 
common chemometric techniques are also 
emphasised; among them. In any case, the 
objective is to build a mathematical model relating 
the molecular descriptors with the experimental 
data, namely the biological activity. 
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2.0  QUANTITATIVE STRUCTURE ACTIVITY 
RELATIONSHIPS (QSAR) 
 
All the various methods used to determine the 
activity demonstrated by certain class of compounds 
either in practical situations or under theoretical 
conditions to achieve the optimum optical activity 
are included under the umbrella of QSAR. According 
to the QSAR method the biological properties of a 
compound and its structural composition are 
intricately linked and this approach tries to define the 
biological or chemical properties of a class of 
compounds under the purview of a mathematical 
model [8-10]. 
Generally compounds with similar structures to a 
chemically active compound are subjected to QSAR 
analysis. Such structurally similar compounds are 
generally developed by minor modifications in the 
original structures. In the next steps the molecular 
descriptors are arranged in a matrix framework and 
are used to describe the characteristic features of 
any molecule. The correlation equation that defines 
the interrelationship between the amount of 
biological activity and the column variables of the 
matrix utilizes these very column variables as 
independent variables. 
Both the statistical methods that are used to 
analyze molecular descriptors and the criteria for 
defining molecular descriptors are included in the 
QSAR technique. In contrast, the field of 
chemometrics only deals with different statistical 
methods that helps in defining mathematical 
interrelationship and making them more accurate 
[11-13]. Any mathematical model thus derived is 
tested by scientists who did not participate in the 
development process and the results derived from 
the model are compared with the actual results. In 
the next step an estimate of the biological activity of 
experimental compounds is done so that they can 
be separated on the basis of their activity and the 
net yield of the process is improved. 
 
 
3.0  ORIGINS AND EVALUATION OF QSAR 
 
3.1  The Birth of QSAR 
 
About 2500 years ago it was Plato who for the first 
time attempted to associate features of chemical 
and physical behavior with structures. According to 
Plato, gasification is a reaction that takes place with 
the conversion of fire into air present in an aqueous 
solution. He made this assumption on the basis of 
reactants structure. 
Even Mendeleev is often considered as an 
ancestor of QSAR because it was his predictions 
about new elements and their characteristics that 
helped him in forming the periodic table of elements. 
In 1869 the periodic table was prepared [14]. 
However it was found that in the nineteenth century 
the first experiments relating a biological response or 
a physicochemical feature of a chain of compounds 
with a structural property were conducted. The 
previous experiments were qualitative in nature. It 
was later on that the quantitative evaluations were 
conducted, where statistical considerations are used 
for relating the bioactivity and a set of parameters 
mathematically. 
Cros in 1863 found that with decreasing solubility of 
the alcohols in water, there was an increase in the 
toxicity of alcohols in mammals [14]. A theory stating 
about an association between physiological 
activities and chemical structures was presented by 
Crum-Brown and Fraser in 1968 [14]. An equation 
connecting changes in both biological activity and 
chemical structure was proposed by them, however 
methods of exemplifying chemical structure on 
quantitative basis was not revealed by them. Based 
on this, the chemical structure as a solubility function 
was proposed by Richardson [14]. 
A Quantitative Structure Property Relationships 
(QSPR) to predict the melting and boiling points in 
homologous series was produced in 1884 by Mills. 
Improved by one degree this prediction was quite 
precise [15]. Afterward, the empirical principle “Plus 
ilssontsolubles, moinsilssonttoxiques”, was determined 
by Richet who connected toxicities of a set of 
alcohols, ethers and ketones with aqueous solubility 
[15]. According to “Plus ilssontsolubles, 
moinsilssonttoxiques” « more solubility means less 
toxity ».  Meyer and Overton from University of 
Marburg and University of Zurich respectively in the 
1900's worked independently and found that it was 
lipophilicity of the organic compounds that 
determined their narcotic abilities [14]. They linked 
partition coefficients to anaesthetic potencies on the 
basis of biological experiments. Moreover, the 
functional groups effecting the increase or decrease 
of partition coefficients were even established by 
Overton. Later, in St. Petersburg Lazarev used 
partition coefficients for developing standards of 
industrial hygiene. Using a log scale he stated the 
correlations, and also produced a system that 
calculates the partition coefficients using structure of 
chemical [14]. 
But the earliest mathematical formulation is 
attributed to Ferguson, who announced a principle 
for toxicity. He observed the increase in anaesthetic 
potency when ascending in a homologous series of 
either n-alkanes or alkanols to a point where a loss of 
potency, or at least no further increase occurred, 
using physical properties such as solubility in water, 
distribution between phases, capillarity and steam 
pressure[15]. 
Prior to the work of Louis P. Hammett in the field of 
organic chemistry, not much development of QSAR 
had happened [16]. Hammett is considered as the 
father of Linear Free Energy Relationships (LFER). 
Indeed, the free modern publications of the Free-
Wilson model [16] and the model of Hansch [17] is to 
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be accredited for the utilization of QSAR approach 
used these days. 
 
3.2  Linear Free-Energy Relationships (LFER) 
 
Hammett in the mid-1930s found that a logical and 
quantitative impact was been applied on the 
dissociation constant by adding substituents to the 
benzoic acid’s aromatic ring of. Also, an equivalent 
impact on the dissociation of other organic acids 
and bases was observed by him [16]. The following 
linear relationship was derived by Hammett from the 
empirical observation. This is also known as the 
Hammett equation (1953): 
Here, a proportionality reaction constant that is 
related to a given equilibrium is signified by the slope 
ρ. This slope links the elements impact on the 
equilibrium with the impact on the benzoic acid 
equilibrium. A factor describing the electronic 
features of aromatic elements, i.e. electron-
withdrawing or donating capability is expressed by σ. 
As these associations evoke the equation 
connecting the free energy, ∆G, with an equilibrium 
constant, K, or rate constant, k, they are known as 
linear free energy relationships. The logarithmic 
relationships connect the reaction energetics with 
the measurements of concentration.  
In the late 1960s, as an order by Hansch and his 
colleagues the Hammett's correlation describing the 
aromatic systems reactivity was involved with the 
QSAR’s unexplored derivation. Moreover, for the first 
time the molecule was divided and its action was 
explained considering its fragments and not by its 
totality. Taft derived the Taft equation [16] by working 
on the steric effects (ES). 
Besides, the influence of field and resonance was 
researched by Swain. The deviation of reactivity of a 
certain electrophilic substrate towards a chain of 
nucleophilic reagents was studied by him. As a result 
the linear free-energy relation also called Swain-Scott 
equation was derived [16]. 
 Here, the nucleophilicity feature of the reagent is 
measured by n and the sensitivity to the 
nucleophilicity of the reagent feature of the substrate 
is measured by s. Moreover, the Swain-Lupton 
equation was derived by him. This equation involves 
a field constant (F) and a resonance constant (R), 
hence it is a dual factor approach to the correlation 
study of elements impacts [16]. Molecular partition 
method of Free and Wilson and Hammett were 
different. According to Free and Wilson considering 
the number, kind and location in the parent skeleton, 
a molecular set biological activity could be 
correlated by adding substituents. Hence, a stabilizer 
model discretizing the activity as a simple sum of 
contributions was formed by them. 
 Here, the molar dose is expressed by C, the 
substituent Xi’s group contribution is indicated by ai 
and the biological activity of the parent structure is 
indicated by µ. The presence or absence of specific 
features of the structure is codified by the descriptors, 
or indicator variables, in this stabilizer model. 
Accordingly the binary values of 1 and 0 are 
assigned to them. 
However Bruice et al. in 1956 had already reported 
the first usage of the Free-Wilson type study [16]. Even 
for considering the possible relations among close 
elements, Free-Wilson models along with crossed 
terms were developed by Bocek and Kopecký [16]. 
Later, the Free-Wilson equation was simplified by 
calculating the non-substituted compound activity 
by Fujita and Ban. For quantifying the participation of 
some particular bonds in an activity that initiates the 
beginning of a carcinogenic result, Daudels, 
Pullmans, and Coulson used valence bond theory 
and molecular orbital theory in their study. The theory 
showing the regions of K and L having a possible 
mechanism of the hydrocarbons was developed on 
the basis of descriptors having theoretical structure 
16]. 
As descriptors of the structure electronic features are 
used by Hammett's relationships on the basis of 
QSAR. When researchers tried to use Hammett-type 
relationships to biological systems they faced 
problem, which showed that it was important to 
have alternative structural descriptors. For predicting 
regularities Hansch and Fujita set up their model on 
empirical searches present among the various 
descriptors and techniques of data analysis, this was 
basically done for dealing with the problems of 
biological systems, free from analysis of Free-Wilson. It 
was for the first time that computers were used 
instead of pencil and paper. 
 
3.3  Hansch Analysis 
 
The research conducted by Robert Muir marked the 
origins of QSAR as applied nowadays. Researching 
on the biological activity of plant growth regulators, 
Robert Muir was a botanist at Pomona College. He 
took help of Corwin Hansch, his colleague in 
chemistry for relating the compounds structures to 
their activities. Afterward, a LFER related model which 
was considered as the formal start for QSAR was 
published by Hansch and Fujita. Two more 
information and application was being added by 
their fragment and additive group contribution 
theory. The first one was using estimated features for 
relating to biological activities, and second was 
acknowledging that the biological action might be 
affected by the various different features. Hence, 
considering this purpose, the use of computer was 
implemented so that it fits in the equation of QSAR 
equations [17]. 
The substituents on a parent molecule in this theory 
from the very beginning have a quantities 
relationship with biological activity.  For considering 
the electronic impact of substituents so that it does 
not lead to meaningful QSAR, Hammett sigma 
parameters was used by them. However, the 
significance of the lipophilicity was understood by 
Hansch, which on biological activity was expressed 
as the octanol-water partition coefficient. A measure 
of the bioavailability of compounds determining the 
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amount of the compound that reaches to the site of 
the target partially is provided by this factor. For 
relating physicochemical features to biological 
activities, the Hansch equation was developed, 
which is in the following manner: 
Here, the molar concentration producing the 
biological impact is represented by C; the partition 
coefficient of octanol/water is expressed by P and 
the electronic Hammett constant by σ. 
For the first time a parabolic model’s definition and 
the blend of diverse physicochemical features were 
allowed in one model, this helped to describe SAR 
which using a single term could not be connected. A 
lipophilicity parameter π could be applied as a 
substitute to values of log P.  The Lipophilicity 
parameter π and the Hammett’s electronic 
parameter σ are described in a similar manner. 
Moreover, Hansch-type associations were created by 
Rudolf Zahradnik quite ahead of its time [17]. 
The utility of both QSAR techniques are broadened 
by the mixed approach of the amalgamation of 
Free-Wilson analysis and Hansch. Several parameters 
are used as descriptors of the structural molecular 
features in order to develop SAR. 
 
3.4  Spatial Methods: 3D-QSAR 
 
Lately, the three-dimensional field of QSAR has been 
introduced due to the need of including the effect of 
the conformations and stereochemistry in studies of 
QSAR. The three-dimensional factors for describing 
compounds are introduced by these new methods; 
this allows computations to the space that is found 
near the molecules. It even needs the molecules’ 
position to a pharmacophore found in general. The 
interaction research of a ligand along with a 
receptor is an application of such QSAR methods; in 
such case in three dimensions the molecules are 
evaluated. Parameters such as electrostatic and 
steric govern these interactions. Stereoisomers, 
enantiomers, and diastereomers are the various 
conformations of the compounds, which are 
considered in this technique. 
The Comparative Molecular Field Analysis, CoMFA 
[18, 19] was the first technique that is about the 
electrostatic and steric molecules interactions with 
their environment. In order to function it considered 
3D shape. Even today in the field of receptor and 
ligand’s modeling this method is commonly used. 
Afterward, the CoMFA superposition method was 
used by Good and Richards [20-22] to compare the 
electronic resemblance between molecules, and 
also they used Neural Networks and Partial Least 
Squares technique to correlate the topological 
indices. 
Moreover, for representing a group of 
conformations there have been the development of 
4D-QSAR [23, 24] and 5D-QSAR [25, 26]. Various 
conformations, states of protonation and orientation 
are presented by this. 
 
 
4.0  MOLECULAR DESCRIPTORS 
 
Describing the molecules and their features is a usual 
problem of QSAR. A very important element of a 
QSAR study is the used descriptors behavior and the 
degree to which the properties of structure 
associated with the biological action are encoded 
by them [27]. Today availability of molecular 
descriptors is more than 3,000 in number [28-30]. 
Commercial software packages like ADAPT [31], 
OASIS [32], and DRAGON [29] can be used to 
calculate these descriptors in theory. 
The topostructural, topochemical, geometrical, 
relativistic, and biodescriptors are among the most 
widely used bibliography available extensivley, and 
stated in increasing complexity order. In different 
manner the important descriptors are categorized, 
these descriptors are used for exemplifying chemical 
compounds. They are classified into three groups: 
i. In the standard models of QSAR the empirical 
factors obtained from organic chemistry, are used, 
for instance the analysis of Hansch. Firstly, these 
models were categorized into electronic, 
hydrophobic, and steric on the basis of numerous 
physicochemical descriptors. However later more 
different descriptors such as solubility, boiling point, 
spectroscopic descriptors, melting point, etc were 
included. 
ii. Characteristics determined theoretically: 
Topological descriptors, factors obtained from 
computational chemistry are included in this group. 
Even the chemicals that are not yet synthesized are 
assessable by these theoretical descriptors. 
iii. Lately, from the eighties, the tridimensional 
descriptors have come into existence. The three-
dimensional molecular structure is considered by 
these factors and is applied in the3D-QSAR methods 
and they may require a molecular super position 
procedure. Molecular similarity indices as well as 
topological quantum similarity indices are included in 
this group. 
Moreover, in the activity the structural features effect 
could be localized to a part of a molecule or it might 
be universal as well. This is another categorization of 
descriptors used commonly. 
 
4.1  Whole Molecule Representations 
 
Complete structures of molecule are used to obtain 
few of these descriptors. Though the molecular 
structures are obtained from the extensions of the 
substituent constant approach, yet many of them 
are entirely new. 
 
4.1.1  Electronic Whole Molecule Descriptors 
 
Obtained from a three-dimensional conformation of 
the molecule, these descriptors, depend on the used 
modeling program. The experimental to semi-
empirical and to quantum mechanical values shows 
the variation in the range of value. Moreover 
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thermodynamics is also the reason behind some of 
these. The commons aspects of the whole molecule 
or local aspects of a particular site are encoded by 
them [33-35]. Polar and energetic descriptors are 
among the electronic descriptors. 
 
4.1.2  Polar Descriptors 
 
The force fields applied on the molecule are 
described by these descriptors. Hence the influence 
or potential of various intermolecular interactions can 
be encoded by them.  
Intermolecular forces. The potential of polar-type 
interactions [35] are encoded by these forces. 
Quantum mechanical methods are used to 
determine it experimentally and calculated 
theoretically. Ion-ion, ion-dipole, dipole-dipole, 
dipole-induced dipole, dispersion forces, hydrogen 
bonding are the interactions by which the 
intermolecular forces arise. 
Molecular polarizability and molar refractivity are a 
measure of a molecule that is polarized. The 
refractive index [36] and the molar volume are used 
to calculate these descriptors. 
Ionization constants. The ionic interactions are 
encoded by these constants and information related 
to the absorption and distribution of a drug are 
provided by them [36]. 
 
4.1.3  Energetic Descriptors 
 
These descriptors are derived from the calculations of 
molecular orbital and electronic interaction is 
defined by them. Electrostatic potentials, bond order, 
atomic charges, number of hydrogen bond donors 
and acceptors, measures of the π-πdonor-acceptor 
ability of molecules, and, specially, reactivity indices 
are few types of such descriptors. 
Reactivity indices. EHOMO or energy of the highest 
occupied molecular orbital is a quantitative measure 
of the chemical reaction of the compound-ionization 
potential of a molecule. ELUMO or energy of the 
lowest unoccupied molecular orbital is the electron 
affinity [37]. However, also the HOMO-LUMO band 
gap energy could be used.  
 
4.1.4  Geometric Descriptors 
 
Information related to the shape and size of active 
compounds, along with the extent of 
complementarity of a ligand and the receptor are 
provided by them. The three-dimensional molecules 
models help in their development, and the 
computations of molecular surface area help to 
obtain them. 
Molecular volume is an overall measure of size of 
molecule. A sphere is placed on each atom having 
radius obtained from the Van der Waals radius of the 
atom to calculate it. Pearlman developed the 
volume estimation method which is used commonly 
[38]. 
Molecular surface area: Lee and Richards [35], 
Herman [35], and Pearlman [36] gave some 
estimation that is used to calculate the molecular 
surface area. 
Charged partial surface area: For understanding 
the features that are affected by polar molecules 
interactions, certain information about surface area 
and charge information are provided charged 
partial surface area [36]. 
 
4.1.5  Topological Descriptors 
 
These descriptors depend on a molecule’s 
connection table and on a molecule’s compressed 
representation of connectivity. However, their values 
might or might not be free of conformation present in 
three-dimension. 
Structure-based descriptors or information-content 
indices 
The occurrence frequency of a substituent or 
substructures found inside molecules as indicator 
variables are counted by these descriptors. These 
variables are bonds and atoms number [35, 36]. 
 
Topological Indices 
 
These are obtained from the graphical 
representation of chemical structures and by 
manipulating the graph-theoretical features of the 
structures [39] they try to encode the size, shape, or 
branching in the compound. The molecular 
connectivity indices[35, 36], Wiener index (sum of the 
chemical bonds found between pairs of heavy 
atoms), Zagreb index (sum of the squares of vertex 
valences), Hosoya index, Kier and Hall molecular 
connectivity index (a chain of numbers chosen by 
order and subgraph focusing on several features of 
atom connectivity) are the most significant indices. 
There are even others such as Molecularflexibility 
index, Kier & Hall valence-modified connectivity 
index, Balaban indices, Kier's alpha-modified shape 
indices and Kier & Hall subgraph count index that are 
equally important. 
 
Electrotopological Descriptors 
 
The electrotopological state indices are numerical 
values computed for each atom in a molecule, 
which encode information about both the 
topological environment of the atom and the 
electronic interactions due to all other atoms in the 
molecule. The topological relationship is based on 
the graph distance to each other atom. 
 
Kappa Indices 
 
Kier developed Kappa indices that are formed by a 
chain of graph theoretical indices. These are 
associated with the shape of the molecule [35] . 
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4.2  Other Descriptors 
 
4.2.1  Receptor Surface Analysis (RSA) Descriptors  
 
The interaction energy found between every point 
on the receptor surface and each model to the 
study table is calculated by these descriptors [35, 36]. 
 
4.2.2  Molecular Field Analysis (MFA) Descriptors  
 
The energy between a probe and a molecular 
model found at a chain of points and described with 
the help of a rectangular or spherical grid is 
calculated by these descriptors [35, 36]. 
 
4.2.3  Molecular Shape Analysis (MSA) Descriptors 
 
These are even known as pharmacophoric 
descriptors or 3DKeys, and are formed by a 
combinations assortment having three properties 
(triplets) and four properties (quadruplets) in the 3D 
space for all conformers. The aspects could be 
negative and positive charges, hydrogen bond 
donors and acceptors, negative and positive 
ionisable groups, aromatic rings and hydrophobic 
groups etc [35, 36]. 
Absorption-Distribution-Metabolism-Excretion (ADME) 
Descriptors: On the basis of profiles such as stability of 
potency, pharmacokinetics, selectivity, and toxicity 
that are need for an ideal drug and the reduction of 
powerful side effects, these descriptors help to 
understand and calculate the responses of drug. The 
cost of drug detection are reduced, the 
development and time of assessment of successful 
candidates are minimized by predicting the difficult 
new chemical bodies at an early stage of 
development, which is done by these ADME 
descriptors [35, 36]. 
 
 
5.0  CONCLUSIONS 
 
It was demonstrated by the Quantitative Structure 
Activity Relationships (QSAR) that the biological 
properties of any compound is determined by its 
structural composition. Therefore, specific molecular 
descriptors were selected to encode the 
association’s degree between the physical and 
chemical structure of a compound and its biological 
action. While the tridimensional descriptors evaluate 
the molecule in a three dimensions, the topological 
descriptors that can determine and assess 
theoretically the characteristics of any studied 
molecule even if it’s not synthesized. All the various 
methods used to determine the activity 
demonstrated by certain class of compounds either 
in practical situations or under theoretical conditions 
to achieve the optimum optical activity are included 
under the umbrella of QSAR. Thus, QSAR has matured 
over the last few decades in terms of the descriptors, 
models, methods of analysis, and choice of 
substituents and compounds. Embarking on a QSAR 
project may be a daunting and confusing task to a 
novice. However, there are many excellent reviews 
and tomes [2, 4, 6, 15, 35, 36] on this subject that can 
aid in the elucidation of the paradigm. Dealing with 
biological systems is not a simple problem and in 
attempting to develop a QSAR, one must always be 
cognizant of the biochemistry of the system analyzed 
and the limitations of the approach used 
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